Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness / Implementation Hybrid Study

遏制尼日利亚青少年艾滋病毒流行的强化组合方法 (iCARE) 加上有效性/实施混合研究

基本信息

  • 批准号:
    10749347
  • 负责人:
  • 金额:
    $ 141.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-08 至 2028-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary Nigeria has the 4th highest global burden of HIV and an uncontrolled epidemic. Among youth aged 15-24, HIV incidence remains high and rates of viral suppression low. The HIV epidemic in Nigeria's youth is highest in men who have sex with men (MSM) and transgender women (TW). Although external (i.e., non-governmental) funders support key population-focused centers to increase access to HIV services for MSM and TW, their reach is limited by dwindling and unsustainable funding. Efforts to improve the capacity of government clinics to reach and care for young MSM (YMSM) and young TW (YTW) as well as to implement effective, scalable, youth-specific interventions with enhanced prevention, improved case-finding, and increased ART access and adherence support for youth living with HIV (YLH) are critical to turn around lagging indicators across the HIV prevention and care continuum. However, to-date, no interventions have undergone rigorous effectiveness and implementation research in Nigeria's complex sociocultural milieu. iCARE Nigeria is a successful NICHD- funded PATC3H research partnership investigating two youth-specific interventions to improve: (1) HIV case- finding and linkage-to-care among YMSM and YTW, and (2) adherence and viral suppression among largely vertically-infected YLH on ART. Each intervention combines evidence-based peer navigation and mHealth strategies adapted to the local context; feasibility and efficacy were shown in a pilot study (UG3). We herein propose iCARE Plus, to scale out and test effectiveness and implementation outcomes on enhanced versions of the iCARE interventions within the newly formed PATC3H-IN. The iCARE Plus Clinical Research Center (CRC) will conduct hybrid effectiveness-implementation trials that will utilize an EPIS (Exploration, Preparation, Implementation, and Sustainment) framework to contextualize intervention implementation in youth aged 15-24 through new Clinical Research Performance Sites (CRPSs) in HIV “hotspots” across Nigeria's six geopolitically distinct zones. Our specific aims are: Aim 1 (Preparation): Implementation preparation will be carried out at selected government clinics in the HIV hotspots, while increasing their capacity and capability to provide services to YMSM and YTW. Aim 2 (Implementation): Test the effectiveness and implementation outcomes of enhanced versions of the iCARE interventions on: 1) HIV case-finding, linkage-to-care and PrEP uptake among YMSM and YTW and 2) viral load suppression in previously unstudied YLH newly-diagnosed and initiating ART. Aim 3 (Sustainment): Promote sustainment of the iCARE initiative and the implementation science capacity development goals of PATC3H-IN by developing a sustainability plan, including economic considerations that leverage ongoing formative research funded by an NICHD supplement, in collaboration with youth, clinic administrators and health ministries and develop IS capacity, building on our Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA)-funded iTRAIN project.
项目摘要 尼日利亚的艾滋病毒负担和疫情失控在全球排名第四。在15-24岁的年轻人中,艾滋病毒 发病率仍然很高,病毒抑制率很低。尼日利亚青年中艾滋病毒流行率最高的是#年 与男性发生性关系的男性(MSM)和变性女性(TW)。虽然是外部的(即非政府的) 资助者支持主要的以人口为重点的中心,以增加MSM和TW获得艾滋病毒服务的机会,他们的 覆盖范围受到资金减少和不可持续的限制。致力提高政府诊所的服务能力 为了接触和照顾年轻男男性接触者(YMSM)和年轻TW(YTW),以及实施有效、可扩展 针对青年的干预措施,加强预防,改进病例发现,增加抗逆转录病毒治疗和 对青年艾滋病毒携带者的坚持支持是扭转艾滋病毒滞后指标的关键 预防和护理连续统一体。然而,到目前为止,没有任何干预措施经历了严格的有效性和 在尼日利亚复杂的社会文化环境中的实施研究。ICARE尼日利亚是一个成功的NICHD- 资助的PATC3H研究伙伴关系调查了两项针对青年的干预措施,以改善:(1)艾滋病毒病例- YMSM和YTW之间的发现和连锁护理,以及(2)大部分患者的依从性和病毒抑制 在ART上垂直感染YLH型。每种干预措施都结合了基于证据的同行导航和mHealth 适应当地情况的战略;试点研究显示了可行性和有效性(UG3)。我们在这里 推荐icare Plus,以横向扩展并测试增强版本的有效性和实施结果 新成立的PATC3H-IN内的ICARE干预措施。ICARE Plus临床研究中心 (CRC)将进行混合有效性实施试验,将利用EPIS(勘探、准备、 实施和可持续)框架,将15-24岁青年干预措施的实施情况纳入背景 通过在尼日利亚六个地缘政治的艾滋病毒热点地区建立新的临床研究绩效网站(CRPS) 不同的区域。我们的具体目标是:目标1(筹备):将在#年开展执行筹备工作 在艾滋病毒热点地区选定的政府诊所,同时增加其能力和提供 为YMSM和YTW提供的服务。目标2(执行):测试以下各项的有效性和执行结果 ICARE干预措施的增强版本涉及:1)艾滋病毒病例发现、与护理的联系和PrEP感染 在YMSM和YTW之间,以及2)以前未研究过的YLH新诊断和 启动艺术。目标3(可持续性):促进维持综合保健方案倡议和执行 PATC3H-IN通过制定可持续发展计划实现科学能力发展目标,包括经济 考虑利用由NICHD附录资助的正在进行的形成性研究 与青年、诊所管理人员和卫生部合作,发展信息和通信技术能力,以青少年艾滋病毒为基础 预防和治疗实施科学联盟(AHISA)资助的iTRAIN项目。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert Garofalo其他文献

Robert Garofalo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert Garofalo', 18)}}的其他基金

MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
MyPEEPS Mobile Plus:针对年轻 MSM 的多层次 HIV 预防干预措施
  • 批准号:
    10818851
  • 财政年份:
    2023
  • 资助金额:
    $ 141.02万
  • 项目类别:
Development and Testing of MyPEEPS Mobile for Young Transgender Men
为年轻跨性别男性开发和测试 MyPEEPS Mobile
  • 批准号:
    10544319
  • 财政年份:
    2022
  • 资助金额:
    $ 141.02万
  • 项目类别:
Development and Testing of MyPEEPS Mobile for Young Transgender Men
为年轻跨性别男性开发和测试 MyPEEPS Mobile
  • 批准号:
    10407736
  • 财政年份:
    2022
  • 资助金额:
    $ 141.02万
  • 项目类别:
Intensive Combination Approach to Rollback the Epidemic (iCARE) in Nigerian Adolescents
尼日利亚青少年抗击疫情的强化组合方法 (iCARE)
  • 批准号:
    10046115
  • 财政年份:
    2020
  • 资助金额:
    $ 141.02万
  • 项目类别:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
mLab 应用程序可提高艾滋病毒快速自我检测的采用率并将青少年与护理联系起来
  • 批准号:
    9927670
  • 财政年份:
    2018
  • 资助金额:
    $ 141.02万
  • 项目类别:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
mLab 应用程序可提高艾滋病毒快速自我检测的采用率并将青少年与护理联系起来
  • 批准号:
    10404092
  • 财政年份:
    2018
  • 资助金额:
    $ 141.02万
  • 项目类别:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
mLab 应用程序可提高艾滋病毒快速自我检测的采用率并将青少年与护理联系起来
  • 批准号:
    10160957
  • 财政年份:
    2018
  • 资助金额:
    $ 141.02万
  • 项目类别:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
mLab 应用程序可提高艾滋病毒快速自我检测的采用率并将青少年与护理联系起来
  • 批准号:
    9755512
  • 财政年份:
    2018
  • 资助金额:
    $ 141.02万
  • 项目类别:
Adaptive intervention strategies trial for strengthening adherence to antiretroviral HIV treatment among youth
加强青少年抗逆转录病毒艾滋病毒治疗依从性的适应性干预策略试验
  • 批准号:
    10371803
  • 财政年份:
    2016
  • 资助金额:
    $ 141.02万
  • 项目类别:
Adaptive intervention strategies trial for strengthening adherence to antiretroviral HIV treatment among youth
加强青少年抗逆转录病毒艾滋病毒治疗依从性的适应性干预策略试验
  • 批准号:
    9357686
  • 财政年份:
    2016
  • 资助金额:
    $ 141.02万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 141.02万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 141.02万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 141.02万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 141.02万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 141.02万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 141.02万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 141.02万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 141.02万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 141.02万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 141.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了